TipRanks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB

Compare Infant Bacterial Therapeutics AB (9IB) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Infant Bacterial Therapeutics AB
€4.48
€80.38M
-10.79
13.36%
―
Hansa Biopharma AB
kr43.30
kr4.00B
-5.01
28.31%
―
BioInvent International AB
kr23.50
kr357.32M
-0.73
-83.69%
―
Xbrane Biopharma AB
kr10.37
kr291.57M
-5.90
35.54%
―
Intervacc AB
kr1.05
kr263.11M
-2.92
-22.80%
―
ExpreS2ion Biotech Holding AB
kr17.10
kr36.86M
-0.14
-84.87%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:9IB
Infant Bacterial Therapeutics AB
5.94
0.51
9.39%
SE:HNSA
Hansa Biopharma AB
39.34
8.34
26.90%
SE:BINV
BioInvent International AB
5.43
-28.47
-83.98%
SE:XBRANE
Xbrane Biopharma AB
14.15
3.35
31.02%
SE:IVACC
Intervacc AB
0.77
-0.20
-20.33%
SE:EXPRS2
ExpreS2ion Biotech Holding AB
0.93
-5.16
-84.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts